4//SEC Filing
WILCOX GARY 4
Accession 0001493152-20-011748
CIK 0001412486other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 6:12 PM ET
Size
5.8 KB
Accession
0001493152-20-011748
Insider Transaction Report
Form 4
WILCOX GARY
DirectorChief Executive Officer
Transactions
- Award
Stock Options (Right to Buy)
2020-06-22+200,000→ 200,000 totalExercise: $1.33Exp: 2030-06-22→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]The stock options are intended to be incentive stock options within the meaning of Section 422 of the Internal Revenue Code. Only $100,000 (or 35,971 options) may first become exercisable by the Reporting Person in each calendar year.
- [F2]The stock options vest as follows: 100,000 stock options will vest on the one year anniversary of the grant date and the remaining 100,000 stock options will vest in eight equal quarterly increments with the first such quarterly increment vesting on September 30, 2021.
Documents
Issuer
Cocrystal Pharma, Inc.
CIK 0001412486
Entity typeother
Related Parties
1- filerCIK 0001222257
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 6:12 PM ET
- Size
- 5.8 KB